Thomas Edward Adrian
#113,984
Most Influential Person Now
Thomas Edward Adrian's AcademicInfluence.com Rankings
Thomas Edward Adrianphilosophy Degrees
Philosophy
#4878
World Rank
#7546
Historical Rank
Logic
#2249
World Rank
#3203
Historical Rank
Thomas Edward Adrianbiology Degrees
Biology
#6492
World Rank
#9220
Historical Rank
Endocrinology
#61
World Rank
#71
Historical Rank
Biochemistry
#834
World Rank
#941
Historical Rank
Download Badge
Philosophy Biology
Why Is Thomas Edward Adrian Influential?
(Suggest an Edit or Addition)Thomas Edward Adrian's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Human distribution and release of a putative new gut hormone, peptide YY. (1985) (1110)
- Neuropeptide Y distribution in the rat brain. (1983) (1100)
- Neuropeptide Y distribution in human brain (1983) (665)
- Prevention of pancreatic cancer induction in hamsters by metformin. (2001) (341)
- Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. (1987) (336)
- Distribution and release of human pancreatic polypeptide. (1976) (320)
- Effect of peptide YY on gastric, pancreatic, and biliary function in humans. (1985) (304)
- MECHANISM OF PANCREATIC POLYPEPTIDE RELEASE IN MAN (1977) (270)
- BREAST vs BOTTLE: ENDOCRINE RESPONSES ARE DIFFERENT WITH FORMULA FEEDING (1980) (252)
- Further characterisation of the 'ileal brake' reflex in man--effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. (1988) (252)
- The distribution and origin of a novel brain peptide, neuropeptide Y, in the spinal cord of several mammals (1984) (227)
- Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. (1994) (218)
- Neuropeptides in Alzheimer type dementia (1983) (218)
- Bombesin: action on gut hormones and calcium in man. (1982) (206)
- PANCREATIC POLYPEPTIDE IN INSULINOMAS, GASTRINOMAS, VIPOMAS, AND GLUCAGONOMAS (1976) (193)
- Peptide YY abnormalities in gastrointestinal diseases. (1986) (189)
- SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions (2020) (188)
- 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. (2002) (182)
- INHIBITION OF PANCREAS AND GALLBLADDER BY PANCREATIC POLYPEPTIDE (1978) (180)
- Effects of peptide YY and neuropeptide Y on gastric emptying in man. (1984) (166)
- Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. (2002) (164)
- Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia. (1983) (162)
- Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest (2006) (162)
- Peptidergic innervation of the human male genital tract. (1983) (158)
- Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas). (1981) (156)
- Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. (1999) (155)
- Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses. (1985) (154)
- The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. (2002) (154)
- Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer (2003) (145)
- Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? (1993) (143)
- NEUROPEPTIDE Y IN PHAEOCHROMOCYTOMAS AND GANGLIONEUROBLASTOMAS (1983) (142)
- Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. (2000) (140)
- Neuropeptide Y (NPY) in the adrenal gland. (1983) (137)
- Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells. (1999) (136)
- Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel (1983) (134)
- Regulatory peptides in the mammalian respiratory tract. (1982) (130)
- Radioimmunoassay of neuropeptide Y (1984) (125)
- A white paper: the product of a pancreas cancer think tank. (2001) (124)
- Gastric juice protects against the development of esophageal adenocarcinoma in the rat. (1996) (123)
- Effects of an elemental diet, inert bulk and different types of dietary fibre on the response of the intestinal epithelium to refeeding in the rat and relationship to plasma gastrin, enteroglucagon, and PYY concentrations. (1987) (122)
- LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. (2005) (120)
- Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers (2012) (120)
- Resveratrol Inhibits Proliferation and Induces Apoptosis in Human Pancreatic Cancer Cells (2002) (119)
- Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in man. (1987) (118)
- Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. (2002) (116)
- Physiological Concentrations of Insulin Augment Pancreatic Cancer Cell Proliferation and Glucose Utilization By Activating MAP Kinase, PI3 Kinase and Enhancing GLUT-1 Expression (2000) (112)
- Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. (1993) (109)
- Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas (2004) (104)
- Plasma motilin, gastrin, and enteroglucagon and feeding in the human newborn. (1980) (102)
- FEEDING AND THE DEVELOPMENT OF ENTEROINSULAR HORMONE SECRETION IN THE PRETERM INFANT: EFFECTS OF CONTINUOUS GASTRIC INFUSIONS OF HUMAN MILK COMPARED WITH INTERMITTENT BOLUSES (1982) (101)
- SUPPRESSION OF PANCREATIC ENDOCRINE TUMOUR SECRETION BY LONG-ACTING SOMATOSTATIN ANALOGUE (1979) (100)
- Gut hormone release after intestinal resection. (1982) (98)
- Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia (1984) (97)
- The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. (1981) (96)
- Distribution and molecular heterogeneity of galanin in human, pig, guinea pig, and rat gastrointestinal tracts. (1986) (94)
- Effect of meal composition and sham feeding on duodenojejunal motility in humans (1992) (93)
- Release of motilin by oral and intravenous nutrients in man. (1979) (91)
- Neuropeptide Y in the human male genital tract. (1984) (89)
- Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia. (2007) (85)
- Pancreatic polypeptide. (1978) (84)
- 12‐lipoxygenase metabolite 12(S)‐HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation (2001) (84)
- Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. (2006) (82)
- Distribution and postprandial release of porcine peptide YY. (1987) (81)
- Distribution and immunocytochemical colocalization of peptide YY and enteroglucagon in endocrine cells of the rabbit colon. (1991) (81)
- Inhibition of secretin stimulated pancreatic secretion by pancreatic polypeptide. (1979) (80)
- Effects of dietary menhaden oil on mucosal adaptation after small bowel resection in rats. (1994) (80)
- Review of the Apoptosis Pathways in Pancreatic Cancer and the Anti‐apoptotic Effects of the Novel Sea Cucumber Compound, Frondoside A (2008) (79)
- Effect of neurotensin on pancreatic function in man. (1981) (79)
- Cyclooxygenases and Lipoxygenases as Potential Targets for Treatment of Pancreatic Cancer (2001) (78)
- Chronic infusion of islet amyloid polypeptide causes anorexia in rats. (1996) (78)
- Peptide YY is a physiological regulator of water and electrolyte absorption in the canine small bowel in vivo. (1993) (78)
- 5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions. (2003) (78)
- Esophagitis in sprague-dawley rats is mediated by free radicals (1995) (76)
- Transdifferentiation of Human Islet Cells in a Long-term Culture (2001) (76)
- Positive correlation between symptoms and circulating motilin, pancreatic polypeptide and gastrin concentrations in functional bowel disorders. (1985) (73)
- Localization and molecular forms of galanin in human adrenals: elevated levels in pheochromocytomas. (1986) (72)
- Guar Sprinkled on Food: Effect on Glycaemic Control, Plasma Lipids and Gut Hormones in Non‐insulin Dependent Diabetic Patients (1987) (71)
- Neurotensin infusion in man: pharmacokinetics and effect on gastrointestinal and pituitary hormones. (1980) (70)
- The intracellular mechanism of insulin resistance in pancreatic cancer patients. (2000) (70)
- Growth hormone and glutamine do not stimulate intestinal adaptation following massive small bowel resection in the rat. (1997) (70)
- Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts. (2011) (69)
- Pancreatic cancer cells selectively stimulate islet cells to secrete amylin (1998) (69)
- Frondoside A Suppressive Effects on Lung Cancer Survival, Tumor Growth, Angiogenesis, Invasion, and Metastasis (2013) (68)
- Arsenic Trioxide Induces Apoptosis in Pancreatic Cancer Cells via Changes in Cell Cycle, Caspase Activation, and GADD Expression (2003) (67)
- N-methylsansalvamide a peptide analogues. Potent new antitumor agents. (2005) (66)
- Regional distribution of bombesin and seven other regulatory peptides in the human brain (1984) (66)
- Secretion of pancreatic polypeptide in patients with pancreatic endocrine tumors. (1986) (66)
- BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation (2008) (65)
- Neuropeptide Y in human spinal cord (1984) (64)
- 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth. (2007) (64)
- Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? (1985) (64)
- Reduction of neuropeptide Y (NPY) in the rabbit iris-ciliary body after chronic sympathectomy. (1983) (64)
- The effect of the mammalian neuropeptide, gastrin-releasing peptide (GRP), on gastrointestinal and pancreatic hormone secretion in man. (1983) (63)
- Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In vivo, In vitro and Network Analyses. (2016) (62)
- Short-chain fatty acid release of peptide YY in the isolated rabbit distal colon. (1991) (62)
- Arsenic Trioxide Causes Redistribution of Cell Cycle, Caspase Activation, and GADD Expression in Human Colonic, Breast, and Pancreatic Cancer Cells (2004) (60)
- Novel marine-derived anti-cancer agents. (2007) (59)
- Altered antroduodenal motility after cholecystectomy. (1994) (59)
- Islet Hormone Secretion in Pancreatic Cancer Patients with Diabetes (1997) (58)
- Pancreatic Stellate Cells (PSCs) express Cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs (2005) (58)
- Pharmacokinetics of pancreatic polypeptide in man. (1978) (58)
- Changing pattern of gene expression is associated with ventricular myocyte dysfunction and altered mechanisms of Ca2+ signalling in young type 2 Zucker diabetic fatty rat heart (2011) (57)
- Impaired pancreatic polypeptide release in chronic pancreatitis with steatorrhoea. (1979) (57)
- Free radical scavengers prevent reflux esophagitis in rats (1995) (57)
- Pancreatic tumours produce neurotensin. (1981) (57)
- LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice. (2005) (56)
- MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1. (2001) (56)
- Plasma trypsin in chronic pancreatitis and pancreatic adenocarcinoma. (1979) (55)
- Intramural distribution of regulatory peptides in the sigmoid-recto-anal region of the human gut. (1988) (54)
- Effect of graded exercise on esophageal motility and gastroesophageal reflux in trained athletes (1993) (54)
- Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions (2001) (54)
- Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas (1978) (54)
- Pancreastatin: a novel peptide inhibitor of parietal cell secretion. (1988) (53)
- Responses of python gastrointestinal regulatory peptides to feeding (2001) (52)
- Factors Affecting Outcome Following Proximal and Distal Intestinal Resection in the Dog (An Examination of the Relative Roles of Mucosal Adaptation, Motility, Luminal Factors, and Enteric Peptides) (1999) (52)
- Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals. (1989) (52)
- Peptide YY: a potential proabsorptive hormone for the treatment of malabsorptive disorders. (1996) (52)
- Proliferative effects of 'fibre' on the intestinal epithelium: relationship to gastrin, enteroglucagon and PYY. (1987) (51)
- Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse. (1998) (50)
- Pancreatic cancer stimulates pancreatic stellate cell proliferation and TIMP-1 production through the MAP kinase pathway. (2004) (50)
- Multiple Signal Pathways Are Involved in the Mitogenic Effect of 5(S)-HETE in Human Pancreatic Cancer (2003) (50)
- On the role of the islets of Langerhans in pancreatic cancer. (2004) (48)
- Effect of pancreatic polypeptide on gallbladder pressure and hepatic bile secretion. (1982) (48)
- Somatostatin inhibits B-cell secretion via a subtype-2 somatostatin receptor in the isolated perfused human pancreas. (1995) (48)
- Effect of hypothalamic neuropeptides on corticotrophin release from quarters of rat anterior pituitary gland in vitro. (1984) (48)
- Maintenance of human islets in long-term culture. (2000) (48)
- Oxidation/reduction of methionine residues in CCK: A study by radioimmunoassay and isocratic reverse phase high pressure liquid chromatography (1985) (47)
- Small intestinal growth caused by feeding red kidney bean phytohemagglutinin lectin to rats. (1993) (47)
- MECHANISM OF PANCREATIC-POLYPEPTIDE RELEASE (1977) (47)
- The Effects of Different Repetitive Transcranial Magnetic Stimulation (rTMS) Protocols on Cortical Gene Expression in a Rat Model of Cerebral Ischemic-Reperfusion Injury (2015) (47)
- Inhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1 (2013) (47)
- Somatostatin and the dumping syndrome. (1985) (46)
- A high omega-3 fatty acid diet mitigates murine pancreatic precancer development. (2011) (45)
- Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations. (1989) (45)
- Hormonal abnormalities of the pancreas and gut in cystic fibrosis (1980) (44)
- Peptide YY kinetics and effects on blood pressure and circulating pancreatic and gastrointestinal hormones and metabolites in man. (1986) (44)
- Gastric Acid Blockade with Omeprazole Promotes Gastric Carcinogenesis Induced by Duodenogastric Reflux (1999) (44)
- Gastrointestinal Regulatory Peptide Responses in Long-Distance Runners (1984) (44)
- LATROGENIC HYPERINSULINISM AT BIRTH (1980) (43)
- A novel anti-pancreatic cancer agent, LY293111 (2005) (42)
- Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets. (1999) (41)
- Effects of Feeding Regimen on Blood Glucose Levels and Plasma Concentrations of Pancreatic Hormones and Gut Regulatory Peptides at 9 Months of Age: Comparison Between Infants Fed with Milk Formula and Infants Exclusively Breast‐Fed from Birth (1988) (41)
- H2-receptor blockade induces peptide YY and enteroglucagon-secreting gastric carcinoids in mastomys. (1989) (40)
- Sufficiency of postprandial plasma levels of islet amyloid polypeptide for suppression of feeding in rats. (1998) (39)
- A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest. (2006) (39)
- In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets. (1998) (39)
- 24-hour variation in content and release of hypothalamic neuropeptides in the rat (1983) (39)
- Gastroesophageal reflux disease is associated with enteric hormone abnormalities. (1994) (38)
- Effects of gastrointestinal hormones on fasting gallbladder storage patterns in man (1979) (38)
- AUTOIMMUNITY IN DIABETICS INDUCED BY HORMONAL CONTAMINANTS OF INSULIN (1979) (37)
- Deoxycholate-stimulated release of peptide YY from the isolated perfused rabbit left colon. (1989) (37)
- Neural regulation of pancreatic polypeptide release. (1983) (37)
- Effect of duodenal components of the refluxate on development of esophageal neoplasia in rats (1998) (37)
- Electrophysiological actions of somatostatin on the atrioventricular junction in sinus rhythm and reentry tachycardia. (1986) (37)
- Effects of voluntary physical exercise on high-fat diet-promoted pancreatic carcinogenesis in the hamster model. (1996) (37)
- Neuroendocrine responses to stimulation of the vagus nerves in bursts in conscious calves. (1983) (36)
- Chromatographic evidence for high‐molecular‐mass galanin immunoreactivity in pig and cat adrenal glands (1986) (36)
- Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer. (2014) (36)
- Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man. (1981) (36)
- Anti-Pancreatic Cancer Effects of a Polar Extract From the Edible Sea Cucumber, Cucumaria frondosa (2010) (35)
- Effect of gut regulatory peptides of intestinal luminal fluid in the rat. (1981) (35)
- Adaptive increase in peptide YY and enteroglucagon after proctocolectomy and pelvic ileal reservoir construction (1991) (35)
- The importance of cholinergic tone in the release of pancreatic polypeptide by gut hormones in man. (1979) (35)
- Malignant diathesis from jejunal-ileal carcinoids. (1989) (35)
- Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines (1997) (35)
- Plasma peptide YY (PYY) in dumping syndrome (1985) (34)
- Effect of LY293111 in combination with gemcitabine in colonic cancer. (2004) (34)
- Effects of exercise training on excitation–contraction coupling and related mRNA expression in hearts of Goto-Kakizaki type 2 diabetic rats (2013) (34)
- Abnormal plasma gut hormones in pathologic duodenogastric reflux and their response to surgery. (1992) (34)
- Gut hormones in acute diarrhoea. (1983) (33)
- Characteristics of the spontaneous gastric endocrine tumor of mastomys. (1988) (33)
- Elevated Plasma Peptide YY in Human Neonates and Infants (1986) (33)
- Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin. (1998) (32)
- Comparison of effects of ingested mediumand long-chain triglyceride on gallbladder volume and release of cholecystokinin and other gut peptides (1987) (32)
- Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells (2007) (32)
- FETAL DISTRESS, MECONIUM, AND MOTILIN (1979) (31)
- Peptide YY augments postprandial small intestinal absorption in the conscious dog. (1994) (31)
- Tachykinins (Substance P, Neurokinin A and Neuropeptide γ) and Neurotensin from the Intestine of the Burmese Python, Python molurus (1997) (31)
- Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. (1983) (31)
- Guar in NIDD: Effect of different modes of administration on plasma glucose and insulin responses to a starch meal (1986) (31)
- Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction? (1989) (31)
- Cellular origin of human pancreatic polypeptide (HPP) in endocrine tumours of the pancreas (1976) (31)
- Pancreatic and gastrointestinal hormones in chronic pancreatitis. (1982) (30)
- Activation of Somatostatin Receptor Subtype 2 Inhibits Insulin Secretion in the Isolated Perfused Human Pancreas (2003) (30)
- Cholecystokinin augmentation of 'surgical' pancreatitis. Benefits of receptor blockade. (1989) (30)
- Contractility of ventricular myocytes is well preserved despite altered mechanisms of Ca2+ transport and a changing pattern of mRNA in aged type 2 Zucker diabetic fatty rat heart (2012) (29)
- Dose-response comparisons of canine plasma gastroenteropancreatic hormone responses to bombesin and the porcine gastrin-releasing peptide (GRP) (1983) (29)
- Dissociated insulin and islet amyloid polypeptide secretion from isolated rat pancreatic islets cocultured with human pancreatic adenocarcinoma cells. (1999) (28)
- Hypotrypsinaemia in diabetes mellitus. (1979) (28)
- Effects of acute and chronic infusion of islet amyloid polypeptide on food intake in rats. (1996) (28)
- On the role of transforming growth factor-β in the growth inhibitory effects of retinoic acid in human pancreatic cancer cells (2007) (28)
- Chronic Low Dose Islet Amyloid Polypeptide Infusion Reduces Food Intake, But Does Not Influence Glucose Metabolism, in Unrestrained Conscious Rats: Studies Using a Novel Aortic Catheterization Technique. (1997) (27)
- Alteration of strain background and a high omega‐6 fat diet induces earlier onset of pancreatic neoplasia in EL‐Kras transgenic mice (2011) (27)
- Adult Cystic stic Fibrosis: Postprandial Response of Gut Regulatory Peptides (1983) (27)
- Response of plasma pancreatic and gastrointestinal hormones and growth hormone to oral and intravenous glucose and insulin hypoglycaemia in Chagas's disease. (1980) (27)
- High concentrations of retinoids induce differentiation and late apoptosis (2005) (27)
- Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster. (1993) (27)
- GROWTH HORMONE RESPONSE TO FEEDING IN TERM AND PRETERM NEONATES (1983) (26)
- Amelioration of cholinergic-induced pancreatitis with a selective cholecystokinin receptor antagonist. (1990) (26)
- Meal‐induced secretion of gastrointestinal regulatory peptides is not affected by sleep (1997) (26)
- Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway. (1996) (26)
- Somatostatin-14 modulates postprandial glucose levels and release of gastrointestinal and pancreatic hormones. (1985) (26)
- Effect of bovine pancreatic polypeptide on basal pancreatic and biliary outputs in man (2005) (25)
- Effects of pancreatic polypeptide on motilin and circulating metabolites in man (1971) (25)
- Early changes in islet hormone secretion in the hamster pancreatic cancer model. (2001) (25)
- Differences in molecular biological, biological and growth characteristics between the immortal and malignant hamster pancreatic cells. (1995) (24)
- Optimization of treatment conditions for studying the anticancer effects of retinoids using pancreatic adenocarcinoma as a model. (1999) (24)
- Cyclic AMP-mediated release of peptide YY (PYY) from the isolated perfused rabbit distal colon (1993) (24)
- The Role of PPARγ Receptors and Leukotriene B4 Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer (2009) (23)
- Effects of long-term infusion of anorexic concentrations of islet amyloid polypeptide on neurotransmitters and neuropeptides in rat brain (2000) (23)
- Lack of effect of pancreatic polypeptide in the rate of gastric emptying and gut hormone release during breakfast. (1981) (23)
- PLASMA SECRETIN IN NEONATES (1980) (23)
- Changes in circulating gut hormones in the horse during long distance exercise. (1982) (23)
- Purification and characterization of islet hormones (insulin, glucagon, pancreatic polypeptide and somatostatin) from the Burmese python, Python molurus (1997) (23)
- Natural retinoids inhibit proliferation and induce apoptosis in pancreatic cancer cells previously reported to be retinoid resistant (2005) (22)
- Hypergastrinaemia of sheep infected with Haemonchus contortus. (1988) (22)
- EFFECT OF SOMATOSTATIN INFUSION ON INTERMEDIARY METABOLISM AND ENTERO‐INSULAR HORMONE RELEASE IN INFANTS WITH HYPERINSULINAEMIC HYPOGLYCAEMIA (1981) (22)
- Proceedings: Radioimmunoassay of a new gut hormone-human pancreatic polypeptide. (1976) (22)
- Effect of reversed intestinal segments on intestinal structure and function. (1995) (22)
- Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways. (2017) (22)
- Effect of single dose of omeprazole on the gastrointestinal peptide response to food. (1984) (21)
- Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway (1996) (21)
- On the role of cholecystokinin in pancreatic cancer (1995) (21)
- A factor from pancreatic and colonic cancer cells stimulates glucose uptake and lactate production in myoblasts. (1999) (21)
- Lipoxygenase inhibitors for the treatment of pancreatic cancer (2003) (21)
- Arsenic trioxide inhibits proliferation and induces apoptosis in pancreatic cancer cells. (2002) (21)
- Feeding premature infants with human milk or preterm milk formula. Effects on postnatal growth and on circulating concentrations of intermediary metabolites, amino acids, and regulatory peptides. (1985) (21)
- The Anti-Cancer Effects of Frondoside A (2018) (21)
- Adult cystic fibrosis: postprandial response of gut regulatory peptides. (1983) (20)
- Receptors and Ligands for Autocrine Growth Pathways Are Up-regulated When Pancreatic Cancer Cells Are Adapted to Serum-Free Culture (2001) (20)
- Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine. (1981) (20)
- Postnatal development of circulating cholecystokinin and secretin, pancreatic growth, and exocrine function in guinea pigs (1993) (20)
- Effect of graded exercise on esophageal motility and gastroesophageal reflux in nontrained subjects (2005) (20)
- Bombesin receptor subtype mediation of gastroenteropancreatic hormone secretion in rats (1994) (19)
- The Regulation of Amylin and Insulin Gene Expression and Secretion (2005) (19)
- Delayed Gastric Emptying and Intestinal Hormones following Pancreatoduodenectomy (2005) (19)
- Pancreatic polypeptide in pancreatitis 1 1 Abbreviations: PP, pancreatic polypeptide; CP, chronic pancreatitis; AP, acute pancreatitis. (2002) (19)
- Effects of a sucrose‐enriched diet on the pattern of gene expression, contraction and Ca2+ transport in Goto–Kakizaki type 2 diabetic rat heart (2014) (19)
- In vitro pancreatic ductal cell carcinogenesis (1997) (19)
- Dissociation of pepsinogen and acid secretion in the guinea pig. (1988) (19)
- Shortening and intracellular Ca2+ in ventricular myocytes and expression of genes encoding cardiac muscle proteins in early onset type 2 diabetic Goto–Kakizaki rats (2012) (18)
- Iatrogenic hyperinsulinism at birth. (1980) (18)
- Pancreatic polypeptide and calcitonin secretion from a pancreatic tumour-clinical improvement after hepatic artery embolization. (1983) (18)
- Different Profile of mRNA Expression in Sinoatrial Node from Streptozotocin-Induced Diabetic Rat (2016) (18)
- PANCREATIC POLYPEPTIDE: A MARKER FOR ZOLLINGER-ELLISON SYNDROME? (1978) (18)
- Alteration of the langerhans islets in pancreatic cancer patients (2000) (18)
- EFFECT OF NEUROMEDIN B ON GUT HORMONE SECRETION IN THE RAT (1984) (18)
- Early regional expression and secretion of peptide YY and enteroglucagon after massive resection of small bowel. (1995) (18)
- The Intracellular Mechanism of Insulin Resistance in the Hamster Pancreatic Ductal Adenocarcinoma Model (1998) (18)
- Gastric somatostatin release: evidence for direct mediation by calcitonin gene-related peptide and vasoactive intestinal peptide. (1988) (17)
- Serum trypsin concentration and pancreatic trypsin secretion in insulin-dependent diabetes mellitus. (1980) (17)
- Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma (2014) (17)
- Biologic instability of pancreatic cancer xenografts in the nude mouse. (2000) (17)
- Hormonal abnormalities of the pancreas and gut in cystic fibrosis. (1980) (17)
- VASOACTIVE INTESTINAL PEPTIDE IN SHOCK AND HEART FAILURE (1983) (17)
- The effect of a long‐acting somatostatin analogue (SMS 201–995) on intermediary metabolism and gut hormones after a test meal in normal subjects (1987) (17)
- Bronchial vasodilator pathways in the vagus nerve of dogs. (1999) (17)
- Luminal short-chain fatty acids and postresection intestinal adaptation. (1996) (17)
- On the Mechanisms of 12-Otetradecanoylphorbol-13-acetate-induced Growth Arrest in Pancreatic Cancer Cells (2006) (17)
- Measurement of cholecystokinin octapeptide using a new specific radioimmunoassay (1985) (16)
- Gastrointestinal hormone in dumping syndrome and reflux esophagitis after gastric surgery. (1997) (16)
- Gut hormone profile in pancreatic disease (1978) (16)
- The Role of Oxygen-Derived Free Radicals and Nitric Oxide in Cytokine-Induced Antiproliferation of Pancreatic Cancer Cells (2002) (16)
- Synthesis and biological activity of C-terminally truncated fragments of human alpha-calcitonin gene-related peptide. (1993) (16)
- Time-Course of Morphologic Changes and Peptide YY Adaptation in Ileal Mucosa After Loop Ileostomy in Humans (2005) (16)
- Pharmacokinetics in Mouse and Comparative Effects of Frondosides in Pancreatic Cancer (2016) (16)
- Islet amyloid polypeptide in the rabbit and European hare: studies on its relationship to amyloidogenesis (1993) (16)
- Structural lesions and changing pattern of expression of genes encoding cardiac muscle proteins are associated with ventricular myocyte dysfunction in type 2 diabetic Goto–Kakizaki rats fed a high‐fat diet (2011) (16)
- Phytochemical drug candidates for the modulation of peroxisome proliferator‐activated receptor γ in inflammatory bowel diseases (2020) (16)
- Effect of duodenal switch procedure on gastric acid production, intragastric pH, gastric emptying, and gastrointestinal hormones. (1992) (15)
- Saffron-based crocin prevents early lesions of liver cancer: In vivo, in vitro and in silico analyses (2016) (15)
- Gastroduodenal mucosal hormone content in duodenal ulcer disease. (1985) (15)
- The role of eicosanoids in the process of adaptation following massive bowel resection in the rat. (2001) (15)
- Effect of intestinal tapering and lengthening on intestinal structure and function. (1995) (15)
- Effect of bovine pancreatic polypeptide on gastric acid and pepsin output in man. (1978) (15)
- A specific histamine-stimulated phosphoprotein in isolated parietal cells. (1987) (15)
- INCREASED PLASMA PANCREATIC POLYPEPTIDE IN CHRONIC ALCOHOL ABUSE (1983) (14)
- Effect of long acting somatostatin-analogue, SMS 201995, on gut hormone secretion in normal subjects (1985) (14)
- FRONDANOL®-A5P FROM THE SEA CUCUMBER, CUCU-MARIA FRONDOSA INDUCES CELL CYCLE ARREST AND APOPTOSIS IN PANCREATIC CANCER CELLS. (2004) (14)
- Distribution and heterogeneity of immunoreactive cholecystokinin (CCK) in the mucosa of the porcine gastrointestinal tract (1984) (14)
- mRNA for pancreatic uncoupling protein 2 increases in two models of acute experimental pancreatitis in rats and mice (2005) (14)
- A micromethod for the assay of cellular secretory physiology: application to rabbit parietal cells. (1989) (14)
- Endothelin-1 levels in ischaemia, reperfusion, and haemorrhagic shock in the canine infrarenal aortic revascularisation model. (1994) (14)
- Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin). (1988) (14)
- EFFECT OF CALCITONIN ON GASTROINTESTINAL REGULATORY PEPTIDES IN MAN (1985) (14)
- Endocrine effects of Haemonchus contortus infection in lambs (1985) (13)
- PLASMA PANCREATIC POLYPEPTIDE IN THE HUMAN NEONATE (1980) (13)
- Peptide YY immunoneutralization inhibits meal-induced absorption in vivo. (1994) (13)
- Effects of raw soya diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster. (1994) (13)
- Leukotriene B 4 Receptor Antagonist LY 293111 Inhibits Proliferation and Induces Apoptosis in Human Pancreatic Cancer Cells 1 (2002) (13)
- Gastrointestinal and pancreatic hormones in the human fetus and mother at 18-21 weeks of gestation. (1995) (13)
- Upregulation of uncoupling protein homologues in skeletal muscle but not adipose tissue in posttraumatic insulin resistance. (2001) (12)
- PLASMA NEUROTENSIN IN TERM AND PRETERM NEONATES (1981) (12)
- Plasma and tissue alterations of peptide YY and enteroglucagon in rats after colectomy. (1992) (12)
- Intraislet somatostatin inhibits insulin (via a subtype-2 somatostatin receptor) but not islet amyloid polypeptide secretion in the isolated perfused human pancreas (1997) (12)
- Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade (1996) (12)
- Frondanol, a Nutraceutical Extract from Cucumaria frondosa, Attenuates Colonic Inflammation in a DSS-Induced Colitis Model in Mice (2018) (12)
- The specificity of amylin for the diagnosis of pancreatic adenocarcinoma (2002) (12)
- Neuropeptide Y in the guinea-pig biliary tract (1984) (12)
- Significance of gastric endocrine tumor and age-related gut peptide alterations in Mastomys (1990) (11)
- Early Gastrointestinal Regulatory Peptide Response to Intestinal Resection in the Rat Is Stimulated by Enteral Glutamine Supplementation (1999) (11)
- Ontogeny of a novel pituitary protein (7B2) in the human fetal intestine (1985) (11)
- Identification and characterization of a cytosolic 30 kDa histamine stimulated phosphoprotein in parietal cell cytosol. (1988) (11)
- Ileoanal pouch function and release of peptide YY (1998) (11)
- Cholecystokinin effect on human lymphocyte ionized calcium and mitogenesis. (1995) (11)
- Qualitative Changes in Enteric Flora and Short-Chain Fatty Acids After Intestinal Resection (1998) (11)
- The Pattern of mRNA Expression Is Changed in Sinoatrial Node from Goto-Kakizaki Type 2 Diabetic Rat Heart (2018) (11)
- Production of antisera using peptide conjugates. (1997) (11)
- Identification and in silico characterization of a novel gene: TPA induced trans-membrane protein. (2005) (11)
- Risk of blood-borne infections in barber shops. (2010) (11)
- Vagotomy and the motor response to feeding. (1980) (11)
- The effect of pirenzepine on meal-stimulated gastrointestinal hormones. (1980) (11)
- Regional differences in concentrations of regulatory peptides in human colon mucosal biopsy (1989) (11)
- An increase in mucosal insulin-like growth factor II content in postresectional rat intestine suggests autocrine or paracrine growth stimulation. (1998) (11)
- Cholecystokinin Mediation of Colonic Absorption Via Peptide YY: Foregut–Hindgut Axis (1996) (10)
- Immunodetection of the presence or absence of full-length APC gene product in human colonic tissues. (1995) (10)
- Plasma trypsin in the diagnosis of steatorrhoea due to chronic pancreatitis (1978) (10)
- Gut hormones in fetal distress (1979) (10)
- Time course of adaptive regulatory peptide changes following massive small bowel resection in the dog (1996) (10)
- Nerolidol Mitigates Colonic Inflammation: An Experimental Study Using both In Vivo and In Vitro Models (2020) (10)
- Plasma trypsin-like immunoreactivity in normal subjects and in patients with pancreatic diseases. (1980) (10)
- Role of the ileocecal junction in the motor response to intestinal resection (1998) (10)
- Role of lipoxygenase pathways in the regulation of pancreatic cancer cell proliferation and survival (2001) (10)
- Release of gastrointestinal hormones following an oral water load (1979) (9)
- Mouth to pouch transit after restorative proctocolectomy: Hydrogen breath analysis correlates with scintigraphy (2001) (9)
- Trophic effects by epidermal growth factor on duodenal mucosa and exocrine pancreas in rats. (1997) (9)
- Effect of a long-acting analogue of somatostatin, SMS 201-995, on the development of intestinal tumours in azoxymethane-treated rats. (1987) (9)
- Intramural distribution of immunoreactive vasoactive intestinal polypeptide (VIP), substance P, somatostatin and mammalian bombesin in the oesophago-gastro-pyloric region of the human gut (1989) (9)
- Amylin gene expression mediated by cAMP/PKA and transcription factors HNF-1 and NFY (2003) (9)
- Intra‐ocular transplantation of carcinoid tumours from Mastomys and humans (1990) (9)
- The effects of naloxone and morphine on postprandial gastrointestinal hormone secretion. (1982) (9)
- Humoral growth factors in plasma and liver tissue during liver regeneration and malnutrition (1994) (9)
- Prostaglandin inhibition of acid is cAMP dependent. (1987) (9)
- Pancreatic exocrine and endocrine responses in chronic pancreatitis. (1984) (9)
- Thymoquinone, a Dietary Bioactive Compound, Exerts Anti-Inflammatory Effects in Colitis by Stimulating Expression of the Colonic Epithelial PPAR-γ Transcription Factor (2021) (9)
- IV chenodeoxycholate prevents calcium bilirubinate gallstones during total parenteral nutrition in the prairie dog. (1996) (8)
- On the potential use of flavonoids in the treatment and prevention of pancreatic cancer. (2005) (8)
- Coeliac sprue: abnormalities of the hormone profile of gastroduodenal mucosa. (1989) (8)
- Cholecystokinin inhibits DNA alkylation induced by N-nitrosobis (2-oxopropyl)amine (BOP) in hamster pancreas. (1992) (8)
- Peptide YY in diabetics treated chronically with an intestinal glucosidase inhibitor (1988) (8)
- Plasma enteroglucagon and CCK levels and cell proliferation in defunctioned small bowel in the rat (1984) (8)
- Are hormonal factors responsible for the intestinal and pancreatic hyperplasia of pancreatico-biliary diversion (PBD)? (1982) (8)
- Measurement and characterisation of human cholecystokinin-like immunoreactivity (CCK-LI) in tissues by radioimmunoassay. (1984) (8)
- Inhibition of pancreatic cancer cell growth (2007) (8)
- On the Importance of Cholecystokinin in Neonatal Pancreatic Growth and Secretory Development in Guinea Pigs (1995) (8)
- The effects of a new amino-acid dipeptide solution on nitrogen balance and humoral growth factors in the postoperative state in man. (1995) (7)
- Hypergastrinemia after vagotomy is not associated with decreased gastric somatostatin. (1989) (7)
- Neuropeptide release from the isolated, perfused, lower esophageal sphincter region of the rabbit and the effect of vasoactive intestinal peptide on the sphincter. (1992) (7)
- Acute Rise of Pancreatic Polypeptide after Electroconvulsive Therapy (1982) (7)
- PANCREATIC POLYPEPTIDE FROM PANCREATIC ENDOCRINE TUMOURS (1980) (7)
- New specific long-acting somatostatin analogues in the treatment of pancreatic endocrine tumours (1978) (7)
- Role of peptide YY and enteroglucagon after low anterior resection (1996) (7)
- Intramural distribution of regulatory peptides in the human stomach and duodenum. (1987) (7)
- Effects of epidermal growth factor on neonatal pancreatic growth in the guinea pig (1998) (7)
- Asperlicin: a unique nonpeptide cholecystokinin antagonist. (1987) (7)
- Chromatographic analysis of tumour-produced hormones (1978) (7)
- Establishment of tumor cell culture (ILA) derived from hamster pancreatic islets treated with BOP (1998) (7)
- Effects of Epidermal Growth Factor, Cholecystokinin, and Secretin on Growth of the Alimentary Tract in the Neonatal Guinea Pig (1998) (7)
- Effects of high-fat diet and cholecystokinin receptor blockade on promotion of pancreatic ductal cell tumors in the hamster. (1997) (7)
- Effects of cholecystokinin and cholinergic receptor blockade on guinea pig pepsinogen secretion. (1990) (6)
- Bile exclusion from the duodenum (1985) (6)
- Sufficiency of postprandial plasma levels of islet amyloid polypeptide for suppression of feeding in rats. (1998) (6)
- Frondoside A potentiates the effects of conventional therapeutic agents in acute leukemia. (2017) (6)
- Schizophrenia — Peptidergic deficits in the limbic system (1982) (6)
- Structure-activity studies on position 14 of human alpha-calcitonin gene-related peptide. (1997) (6)
- Ileal Transposition in Rats Reduces Energy Intake, Body Weight, and Body Fat Most Efficaciously When Ingesting a High-Protein Diet (2020) (6)
- Pepsin release by prostaglandin E1 analogue. A potential therapeutic problem. (1988) (6)
- Regulatory peptide distribution in separated layers of the human jejunum. (1987) (6)
- Somatostatin analogue inhibition of isolated parietal cell secretion. (1987) (6)
- Lymph, pancreatic and gastrointestinal hormones in response to feeding in the conscious pig. (1985) (6)
- Cholecystokinin receptor antagonists. (1988) (6)
- Lack of peptide YY immunoreactivity in adenomatous colonic polyps: evidence in favor of an adenoma-carcinoma sequence. (1988) (5)
- Altered profile of mRNA expression in atrioventricular node of streptozotocin-induced diabetic rats (2017) (5)
- Studies on the release of pancreatic polypeptide and its relationship to pancreatic exocrine function [proceedings]. (1977) (5)
- Effects of ischaemia and reperfusion on vasoactive neuropeptide levels in the canine infrarenal aortic revascularization model. (1996) (5)
- Somatostatin inhibition of intrinsic factor secretion from isolated guinea pig gastric glands. (1987) (5)
- Establishment and characterization of a new, spontaneously immortalized, pancreatic ductal cell line from the Syrian golden hamster (1995) (5)
- The Release of Gastrin, PP, Vip and Motilin after an Oral Water Load and Atropine in Man (1978) (5)
- Bombesin infusion in man, pharmacokinetics and effect on gastro-intestinal and pancreatic hormonal peptides [proceedings]. (1979) (5)
- Effect of Peptide YY and Neuropeptide Y on the Rate of Gastric Emptying in Man (1985) (5)
- Release of motilin in man by oral and intravenous nutriments (1978) (5)
- Pepsinogen release and acid secretion from human and guinea pig gastric mucosa compromised by hypoxia, endotoxin, or critical illness. (1990) (5)
- α-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR-γ Transcription Factor: In Vivo and In Vitro Study (2022) (5)
- Rat immunoreactive cholecystokinin (CCK): characterization using two chromatographic techniques (1985) (5)
- Differential inhibition of insulin and islet amyloid polypeptide secretion by intraislet somatostatin in the isolated perfused human pancreas. (1999) (4)
- ErbB2 Growth Factor Receptor, a Marker for Neuroendocrine Cells? (2005) (4)
- Abstract of the Symposium (1994) (4)
- Role of the ileocecal junction in the motor response to intestinal resection. (1998) (4)
- Peptides bind to eosinophils in the rat stomach (1998) (4)
- Chronic low dose islet amyloid polypeptide infusion reduces food intake, but does not influence glucose metabolism, in unrestrained conscious rats: studies using a novel aortic catheterization technique. (1997) (4)
- Frondanol® A5: A novel nutrapreventive and therapeutic agent derived from sea cucumber showing promising antiproliferative, antiinflammatory and antiangiogenic activities. (2006) (4)
- Radioimmunoassay of the APC gene product using antibodies against its middle and carboxyl regions. (1995) (4)
- Clinical application of the atropine test for diagnosis of pancreatic PP'omas (1983) (4)
- A novel micromethod for pancreatic acinar secretion (1990) (4)
- Red oil A5 inhibits proliferation and induces apoptosis in pancreatic cancer cells. (2004) (4)
- Lipoxygenase expression in colon polyps and inhibition of colon cancer growth by lipoxygenase blockade (2004) (4)
- Inhibition of Cytochrome P450 and Multidrug Resistance Proteins Potentiates the Efficacy of All-Trans Retinoic Acid in Pancreatic Cancer In Vitro and In Vivo (2015) (4)
- Smooth muscle contractility after intestinal resection. (1996) (4)
- Somatostatin and analogs lack splanchnic vasoconstrictive effects in anesthetized pigs. (1987) (4)
- Carboxyfluorescein and biotin neuromedin C analogues: Synthesis and applications (1995) (4)
- Glucagon, stress, and portal hypertension (1995) (4)
- THE INFLUENCE OF ADRENERGIC DENERVATION ON THE RESPONSE TO FEEDING OF THE GASTROENTEROPANCREATIC SYSTEM IN MAN (1984) (4)
- Effects of jejunoileal autotransplantation on gastrointestinal regulatory peptides (1994) (4)
- Adaptive Gastrointestinal Hormone Changes after Gastric Resection (1997) (3)
- Importance of gut hormones in gastrointestinal, metabolic, and malignant diseases (2005) (3)
- How to assess the physiological role of a new peptide hormone: pancreatic polypeptide infusion in man [proceedings]. (1979) (3)
- Islet amyloid polypeptide tonally inhibits b-, a-, and d-cell secretion in isolated rat pancreatic islets (1998) (3)
- Anti-Inflammatory Effects of Compounds from Echinoderms (2022) (3)
- The release of gastrointestinal hormones following an oral water load and atropine in man (1978) (3)
- Effect of food on porcine gut regulatory peptides in arterial and portal venous blood. (1985) (3)
- Smooth muscle adaptation after intestinal transection and resection (2005) (3)
- THE ROLE OF EICOSANOID SYNTHESIS IN INTESTINAL ADAPTATION (1999) (3)
- Enteric neuropeptide abnormalities following small bowel resection and the effect of a tapering and lengthening procedure. (1996) (3)
- Plasma cholecystokinin response to food in healthy subjects (1984) (3)
- 1,2,3-Triazolyl ester of ketorolac (15K), a potent PAK1 blocker, inhibits both growth and metastasis of orthotopic human pancreatic cancer xenografts in mice. (2019) (3)
- Glucagon, stress, and portal hypertension. Plasma glucagon levels and portal hypertension in relation to anesthesia and surgical stress. (1995) (3)
- Inhibition ofsecretin stimulated pancreatic secretion bypancreatic polypeptide (1978) (3)
- DIFFERENCES IN ALIMENTARY HORMONE RESPONSES BETWEEN BREAST AND BOTTLE-FED INFANTS: 87 (1980) (3)
- Ventricular myocyte contraction, intracellular calcium and expression of genes encoding cardiac muscle proteins in young and aging Zucker diabetic fatty rat heart reviewed (2012) (3)
- Effects of portal vein stenosis and superior mesenteric vein ligation on mesenteric venous pressure and porta-systemic shunting in the rat. (1994) (3)
- Establishment of Human Pancreatic Ductal Cells in a Long-Term Culture (2000) (3)
- THE LEUKOTRIENE RECEPTOR: BLT2R IS OVEREX-PRESSED IN PANCREATIC INTRAEPITHELIAL NEOPLASTIC LESIONS (PANINS): A NEW TARGET FOR THERAPY? (2004) (3)
- Intramural distribution ofregulatory peptides inthe sigmoid-recto-anal regionofthehumangut (1988) (2)
- Effect of partial ileal bypass on the gut hormone responses to food in man. (1983) (2)
- The effects of naloxone on circulating metabolites, glycoregulatory hormones and gut peptides during pelvic surgery. (1983) (2)
- The effect of a synthetic enkephalin analogue on postprandial gastrointestinal and pancreatic hormone secretion. (1983) (2)
- Physiologic significance of cholecystokinin in mammalian pepsinogen secretion (1987) (2)
- Could islet amyloid polypeptide (IAPP) contribute to the cachexia of pancreatic cancer patients (1993) (2)
- Codeine phosphate abolishes the pancreatic polypeptide response to oral fat (1982) (2)
- The continuing hormonal contamination of insulin (1985) (2)
- Motility and other Disorders of the Biliary Tract (2008) (2)
- ON THE MECHANISM OF TPA-INDUCED GROWTH ARREST IN PANCREATIC CANCER CELLS. (2004) (2)
- Gastrointestinal growth factors and pancreatic islet hormones during postoperative IGF-I supplementation in man. (2000) (2)
- Corrigendum: Differences in molecular biological, biological and growth characteristics between the immortal and malignant hamster pancreatic cells (Carcinogenesis (1995) 16 (931-939)) (1995) (2)
- SANSALVAMIDE ANALOG INDUCES G1 CELL-CYCLE ARREST THROUGH UP REGULATION OF P21 AND DOWN REGULATION OF CDK4 AND CYCLIN E IN PANCREATIC CANCER CELLS (2008) (2)
- PP in patients with the carcindid syndrome, pancreatic endocrine tumours and adenocarcinomas (1978) (2)
- Abstract 1382: The sea cucumber-derived anti-cancer triterpenoid, Frondoside A blocks angiogenesis (2010) (2)
- Studies on the mechanism of action of frondoside A in pancreatic cancer (2013) (2)
- Decreased parietal cell secretory capacity following vagotomy and pyloroplasty. (1989) (2)
- MOTILIN ENHANCES GALLBLADDER PRESSURE IN THE PIG (1982) (2)
- Prostaglandin E analogue inhibition of intrinsic factor release. (1988) (2)
- Prostaglandin E Analogue Inhibition of Pancreatic Enzyme Secretion (1989) (2)
- Response of the terminal ileum to intestinal resection and bypass. (1996) (2)
- Apigenin causes growth arrest in pancreatic cancer cells through down-regulation of the replication inhibitor protein, Geminin via both transcription and ubiquitin-mediated degradation (2006) (1)
- LY293111 improves gemcitabine efficacy in a new fluorescent orthotopic model of pancreatic cancer in athymic mice (2003) (1)
- Effect of protease inhibitors on peptide-stimulated amylase secretion from dispersed pancreatic acini (1995) (1)
- Rna -seq Study Of Muscle And Adipose Tissue In Cancer Patients With Early Cachexia (2014) (1)
- Plagiarized and inaccurate papers in the World Journal of Gastroenterology. (2004) (1)
- PANCREATIC CANCER CELL CYCLE ARREST AND APOPTOSIS ARE INDUCED BY A NOVEL DEPSIPEPTIDE SANSALVAMIDE ANALOGUE (2005) (1)
- The effect of meal composition and sham feeding on duodeno-jejunal motor activity in man (1990) (1)
- Layer separation of the human bowel for the study of regulatory peptides (1982) (1)
- A novel micromethod for pancreatic acinar secretion. Time course of CCK stimulation and its inhibition by L-364,718. (1990) (1)
- Abstract 5249: Crocin prevents early lesions of liver cancer:system biology approach (2016) (1)
- The prognostic value of apoptotic marker ( CD 95 ) in adult acute leukemias (2017) (1)
- β-Myrcene Mitigates Colon Inflammation by Inhibiting MAP Kinase and NF-κB Signaling Pathways (2022) (1)
- Frondanol-A5 from cucumaria frondosa induces cell cycle arrest and apoptosis in pancreatic cancer cells (2004) (1)
- Neuropeptide content in rat hypothalami and their release in vitro from tissue (1982) (1)
- Influence of Somatostatin on Postprandial Hormone Release (1982) (1)
- GUT HORMONES IN THE NEONATE: 72 (1980) (1)
- Plasma Trypsin in Patients with Steatorrhoea Due to Chronic Pancreatitis (1978) (1)
- Normal enteric peptides and neuronal morphology in the autotransplanted gut (1990) (1)
- APIGENIN INHIBITS HUMAN PANCREATIC CANCER CELL PROLIFERATION THROUGH G2/M CELL CYCLE ARREST. (2004) (1)
- Localisation and Molecular Forms of Galanin in Phaeochromocytomas and Human Adrenals (1985) (1)
- Is impaired insulin-receptor binding involved in the impaired glucose metabolism and cachexia of pancreatic cancer patients? (1993) (1)
- EFFECTS OF GENETIC AND EPIGENETIC EVENTS ON MUTANT KRAS-INDUCED CARCINOMA IN SITU. (2004) (1)
- Abundance of VIP in duodenal mucosa of coeliacs and duodenal ulcer patients (1984) (1)
- Investigational strategies for detection and intervention in early-stage pancreatic cancer (1994) (1)
- Apigenin enhances gemcitabine-induced pancreatic cancer cell apoptosis (2004) (1)
- Anomalous elution of CCK-8 from gel chromatographic columns (1984) (1)
- Life threatening diarrhoea ultimately cured by surgery. (1998) (1)
- LOSS OF PIGMENT EPITHELIUM-DERIVED FACTOR (PEDF) EXPRESSION ENHANCES PANCREATIC INTRAEPITHELIAL NEOPLASIA (PANIN) FREQUENCY AND PANCREATIC FIBROSIS IN VIVO (2005) (1)
- Effects of Profound Duodenogastric Reflux on the Foregut in Rats (1997) (1)
- TRANSCRIPTIONAL CHANGES IN PANCREATIC CANCER CELLS TREATED WITH FRONDOSIDE A (2005) (1)
- Effects of Duodenal Perfusion of Sodium Taurocholate on Biliary and Pancreatic Output and Gut Hormone Release in Man (1979) (1)
- Effect of naloxone on the antral motor response to solid food in man (1987) (1)
- Localization and characterization of galanin immunoreactivity in the human, pig and cat adrenal: Molecular heterogeneity due to N- and C- terminal extension of the galanin molecule (1985) (1)
- Distribution and postprandial release of porcine peptide YY (PYY) (1986) (1)
- Neuropeptide Y (NPY) Concentrations Are Elevated in the Substantia Innominata in Alzheimers Type Dementia (1984) (0)
- Positive correlation between symptomsandcirculating motilin, pancreatic polypeptide andgastrin concentrations infunctional bowel disorders (1985) (0)
- Impaired PP release in chronic pancreatitis with steatorrhoea Table Chronic pancreatitis (2006) (0)
- DEVELOPMENT OF METAPLASTIC PRECURSOR LESIONS IN MURINE PANCREAS FOLLOWING MUTANT KRAS EXPRESSION IN ADULT PDX1-POSITIVE CELLS (2007) (0)
- Purification and characterization of islet hormones ( insulin , glucagon , pancreatic polypeptide and somatostatin ) from the Burmese python , Python (1997) (0)
- Influence of malnutrition on humoral growth factors in plasma and liver tissue during liver regeneration (1993) (0)
- Effects of IGF-I on pancreatic and gut hormones, growth factors, and protein metabolism after colectomy in man (1995) (0)
- 161 THE EFFECTS OF LOW VS HIGH INTENSITY EXERCISE ON THE RESPONSE TO AN ORAL GLUCOSE TOLERANCE TEST IN INSULIN RESISTANT SUBJECTS (1994) (0)
- Response ofplasma pancreatic andgastrointestinal hormones andgrowth hormone tooraland intravenous glucose andinsulin hypoglycaemia in Chagas's disease (2011) (0)
- Dramatic plasma CCK elevation results from dietary enzyme inhibitor (1983) (0)
- Studies on the nature, distribution, release, physiology and pathophysiology of pancreatic polypeptide. (1980) (0)
- Contents, Vol 31, 1985 (1985) (0)
- Peptide YY a Sensitive Indicator of Impaired Carbohydrate Digestion (1986) (0)
- CHARACTERIZATION OF TTMP, A NOVEL GROWTH-RELATED GENE, IN PANCREATIC CANCER (2005) (0)
- Gastrointestinal Hormone Response to Sham Feeding (1983) (0)
- Visions & Reflections (Minireview) Inhibition of pancreatic cancer cell growth (2007) (0)
- Hormones and growth factors in pancreatic cancer (1992) (0)
- Insulin augments pancreatic cancer cell proliferation and glucose utilization by activating both MAP kinase and PI-3 kinase (1997) (0)
- The specificity of amylin for the diagnosis of pancreatic cancer (2000) (0)
- CHANGES IN EXPRESSION OF CELL CYCLE-ASSOCIATED GENES ACCOMPANY RETINOIC ACID-INDUCED GROWTH ARREST IN PANCREATIC CANCER CELLS. (2004) (0)
- Identification of a novel gene product: Resveratrol-Induced Nuclear Protein (RINP) (2006) (0)
- COX-2 EXPRESSION IN EL-POSITIVE CELLS INDUCES ABERRANT DUCT DEVELOPMENT (2008) (0)
- Pharmacokinetics and comparative effects of frondosides in pancreatic cancer (2013) (0)
- Increased Pyy Release in the Dumping Syndrome is Suppressed by Somatostatin (1985) (0)
- Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies (2023) (0)
- Involvement of P21/WAF1 and cyclin E in induction of pancreatic cancer cell G0/G1 arrest and apoptosis by a novel peptide sansalvamide analogue (2005) (0)
- Effects of Peptide YY on CCK/CCK Antagonist Interactions in Cerulein‐induced Pancreatic Injury (1995) (0)
- Importance of the Distal Gut Hormone, PYY following Surgery for Gastrointestinal Disease, Malignancy or Obesity (2005) (0)
- Subject Index, Vol. 30, 1984 (1984) (0)
- A New Specific Assay for Cholecystokinin Octapeptide (1985) (0)
- The effects of a new glutamine-dipeptide containing amino-acid solution on protein metabolism and humoral growth factors in the postoperative state in man (1994) (0)
- Expression of 5-Lipoxygenase (5-LOX) and cyclooxygenase-2 (COX-2) in rat acinar cells increases in acute necrotizing pancreatitis (2003) (0)
- Association of massive pepsin release with 'stress' gastritis (1988) (0)
- P-133 Barriers to Exclusive Enteral Nutrition for Induction of Remission of Childhood Crohn's Disease: Qualitative Analysis of a Randomised Controlled (2014) (0)
- Endocrine abnormalities in the pancreas and gut of the obese hyperglycaemic (ob/ob) mouse [proceedings]. (1979) (0)
- Secretion of EGF and TGF-α by the distal esophagus in response to acid, pepsin and pancreatic enzymes (1998) (0)
- A novel TPA-induced transmembrane protein, TTMP regulates pancreatic cancer cell proliferation through the Rb pathway (2006) (0)
- Screening of gastrointestinal hormone release in patients with lung cancer. (2003) (0)
- Neuropeptide Y levels during ischemia and reperfusion in the canine infrarenal aortic revascularization model (1994) (0)
- Molecular Docking Identifies 1,8-Cineole (Eucalyptol) as A Novel PPARγ Agonist That Alleviates Colon Inflammation (2023) (0)
- EFFECTS OF LOW INTENSITY EXERCISE DURATION ON INSULIN RESPONSE TO A GLUCOSE TOLERANCE TEST: 1206 (1995) (0)
- P-134 The Optimum Length of Enteral Nutritional Therapy for Induction of Remission in Paediatric Crohn's Disease: A Randomised Controlled Feasibility Trial (2014) (0)
- Trophic effects of ileal hormones (1983) (0)
- SPROUTY2 EXPRESSION IN HUMAN PANCREATIC CANCER CELLS AND CHARACTERIZATION OF THE SPROUTY2 PROMOTER. (2004) (0)
- A novel sansalvamide analogue inhibits pancreatic cancer cell proliferation via induction of macrophage inhibitory cytokine (MIC-1) (2006) (0)
- Development of gut hormone secretion in the pre-term neonate: Comparison of continuous intragastric infusions of human milk with intermittent boluses (1982) (0)
- O.57 Islet amyloid polypeptide reduces food intake atplasma levels that are observed in cachectic pancreatic cancer patients (1996) (0)
- Contents, Vol. 14, 1997 (1997) (0)
- Free Radical Scavengers Prevent Esophagitis in Rats Reflux (1995) (0)
- The mechanism of abnormal pancreatic beta cell response to food following acute hypoglycaemia in man. (1981) (0)
- The role of the PAK-1 inhibitor, Frondoside A in the treatment of cancer (2017) (0)
- Marked changes in pancreatic polypeptide and motilin release in different T types of functional bowel disorder (1983) (0)
- Subject Index, Vol 31, 1985 (1985) (0)
- Subject Index Vol. 14, 1997 (1997) (0)
- Human Gall Bladder and Gut Hormone Responses to Ingested Medium Chain Triglyceride (MCT) and Long Chain Triglyceride (LCT) (1983) (0)
- Effects of Ischaemia and Reperfusion on Vasoactive Neuropeptide Levels in the Canine Infrarenal Aortic Revascularization Model (1996) (0)
- The gut hormones and their roles in obesity and gastric restrictive surgery (2003) (0)
- Study protocol for a pilot randomized, double-blind, placebo-controlled trial to investigate the anti-inflammatory effects of Frondanol in adults with inflammatory bowel disease (2022) (0)
- Gut hormone release by intraduodenal stimulation in duodenal ulcer patients. (1989) (0)
- Author lndex Vol. 14, 1997 (1997) (0)
- Endocrine abnormalities in the pancreas and gut of the obese hyperglycaemic (ob/ob) mouse. Abstr. (1979) (0)
- Expression of prostaglandin E-receptors in pancreatic cancer (2004) (0)
- Effects of exercise training on excitation–contraction coupling and related mRNA expression in hearts of Goto-Kakizaki type 2 diabetic rats (2013) (0)
- Malnutrition increases m-RNA expression of EGF and EGF-receptor in liver tissue (1994) (0)
- Radioimmunoassay of regulatory peptides in the presence of acetonitrile: marked improvement of cholecystokinin assays (1998) (0)
- How to Build a Pancreas (1998) (0)
- Abstracts from a Workshop on Pancreatic Cancer Organized by the Swedish Cancer Society (1994) (0)
- Abnormal Insulin Secretory Response to Food after Acute Hypoglycaemia in Man: Evidence for β-Cell Glucopenia (1980) (0)
- Further characterisation ofthe'ileal brake' reflex in man-effect ofileal infusion ofpartial digests offat, protein, andstarch onjejunal motility andrelease of neurotensin, enteroglucagon, andpeptide YY (1988) (0)
- Release ofmotilin byoral andintravenous nutrients inman (2011) (0)
- Inhibition of Cytochrome P 450 and Multidrug Resistance Proteins Potentiates the Efficacy of All- Trans Retinoic Acid in Pancreatic Cancer In Vitro and In Vivo (2016) (0)
- Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women (2023) (0)
- Distribution of Neuropeptide Y in Post Mortem Human Brain from Normal and Schizophrenic Subjects (1983) (0)
- P.16 IAPP induced anorexia in the rat can be partially reversed by an IAPP antagonist (1997) (0)
- Association for Academic Surgery, 2006 Resveratrol Inhibits Pancreatic Cancer Cell Proliferation Through Transcriptional Induction of Macrophage Inhibitory Cytokine-1 1 (2007) (0)
- REGULATION OF P21WAF1 TURNOVER BY RETINOIC ACID IN PANCREATIC CANCER CELLS. (2004) (0)
- Hypersecretion and molecular heterogeneity of peptide YY-like immunoreactivity in human neonatal plasma (1986) (0)
- Contents Vol. 5, 2005 (2005) (0)
- Physiology of the porcine gastrointestinal regulatory peptides. (1981) (0)
- TPA-induced transmembrane protein (TTMP) induces growth arrest in pancreatic cancer cell lines and its expression is downregulated in human pancreatic adenocarcionoma (2008) (0)
- IS 15-LIPOXYGENASE-1 A TUMOR SUPPRESSOR IN PANCREATIC CANCER? (2006) (0)
- Pancreatic cancer cells selectively stimulate beta islet cells to secrete IAPP (1996) (0)
- Pharmacokinetics ofpancreatic polypeptide inman (1978) (0)
- Contents, Vol. 22, 1985 (1985) (0)
- Frondoside A potentiates the effects of conventional therapeutic agents in acute leukemia (2016) (0)
- Subject Index Vol. 5, 2005 (2005) (0)
- Gastroduodenal mucosal VIP levels in coeliac sprue and duodenal ulcer disease (1983) (0)
- LAPSG Society News (2005) (0)
- DISSECTING THE MOLECULAR PATHWAYS INVOLVED IN THE ANTI-CANCER EFFECTS OF RESVERATROL USING OLIGONUCLEOTIDE MICROARRAY (2005) (0)
- Subject Index, Vol. 22, 1985 (1985) (0)
- P400Effects of a sucrose-enriched diet on the pattern of gene expression, contraction and Ca2+ transport in Goto-Kakizaki type 2 diabetic rat heart (2014) (0)
- The role of pancreatic and nonpancreatic hormones in normal pancreatic function and growth (1992) (0)
- Crosstalk between the 5-lipoxygnease and EGF-MAPK pathway in pancreatic cancer (2015) (0)
- Effects of diabetes mellitus and exercise training on expression of mRNA, contraction and calcium transport in the adult Goto-Kakizaki rat heart (2013) (0)
- Induced nitric oxide synthase and diabetic cardiomyopathy (2015) (0)
- 4th Meeting of Mediterranean Societies of Pancreatology (2005) (0)
- P.120 Chronic elevation of circulating islet amyloid polypeptide does not effect peripheral insulin sensitivity in the conscious unrestrained rat (1995) (0)
- Gastrointestinal hormone abnormalities in duodenogastric reflux disease and the response to pancreatico-biliary diversion (1992) (0)
- Gastrointestinal hormone altering in cancer patients (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas Edward Adrian?
Thomas Edward Adrian is affiliated with the following schools:
